
SKS Life
Sciences Group
Where strategy meets execution -
at the intersection of pharmaceuticals, biotech, medical device and digital health.
Who we are
We’re experts in building the future of healthcare
- leveraging ai, data, patient support & modern care delivery models
Our roots are in biopharma and we’re pioneers in digital health. We know how to navigate and execute regulatory and organizational complexity.
We design compliant strategies and solutions that deliver results across medical, commercial, and access teams — which is why the industry trusts us to lead the way on innovation.

We Bring Clarity to Complexity
SKS Life Sciences Group helps pharma, biotech, and digital health teams move faster using our unique operational expertise to give you an edge.
From building the biopharma industry’s first DTP platforms to designing medical, access and commercial strategies for product launch to implementing the use of ai and data - our work drives real-world results that help patients.
Pharma
Full-Stack Strategy & Execution Across the Drug Development Lifecycle - DTP Platform KOLs
We help pharmaceutical teams design and launch compliant, patient-centric, data-driven, ai-enabled programs that accelerate clinical and commercial impact.
Digital Health
Pharma-Facing GTM, Growth + Product Strategy & Launch Solutions - Fractional Commercial Team
We partner with digital health companies to break into life sciences, scale enterprise partnerships, and build what pharma actually needs.
Brand Building & Strategic Communications
Narratives That Move: Messaging, Branding & Experience Design - Fractional Marketing Leadership
We craft emotionally resonant, patient, HCP, and media ready communications that align with brand, product, and purpose across every stakeholder touchpoint, elevating the story.
Biotech & Med Device
Commercial, Market Access & Reimbursement and Medical Strategy for Launch Readiness + BD
We guide emerging biotech and device teams through clinical, regulatory, and market launch strategy to unlock value and drive toward commercialization.
Capital Raising & Financing
Strategic Fundraising Support for Existing SKS Partner Companies
From pitch to close, we provide access to our network of 50+ specialized investors to support our Partner companies to position, prepare, and connect with the right investors to fuel their bold ambitions.
Limited Companies.

Sasha Khursheed and Kirsten have a rare ability to translate pharma’s need for scalable, patient-centric solutions into elegant, compliant products — it’s why they work with the Top 50 pharma companies globally.
Joe Keenan
SVP Life Sciences, LetsGetChecked (ex-Novartis)
Select SKS Partner Companies

Our work, by the numbers
100%
of the SKS Team
Experts in operating Emerging Care Delivery Models (DTP, Connected Care, At-Home Dx, Rx Delivery, Digital Therapeutics, & More)
50+
Pharma Customer Intros and Counting
We have made countless introductions to prospective and existing customers for SKS Partner companies
100+
Product Launches
Therapies, diagnostics, med devices and digital health products brought to market by the SKS Team across all Therapeutic Areas.
250+
Network of Top 40 Pharma Executives
Our connections in pharma and biotech span a collective 200+ years in life sciences across all Therapeutics Areas
2
Weeks
Our shortest turnaround time to complete targeted interviews with pharma and biotech buyers and KOLs — delivering actionable insights fast.
100+
Pharma Interviews Conducted Annually
Ongoing conversations with industry leaders fuel our DTP strategies, GTM, market intelligence, and real-time voice-of-customer insights
$5B
Raised
The SKS Team have supported companies that collectively raised over $5B—including $1B through direct capital raising leadership.
50
Specialized Investors
We work with a network of institutional and strategic investors interested in biotech, digital health, AI, and data infrastructure in life sciences.
1st
DTP Pharma Platforms
Built or advised 4 Top 20 pharma on their first direct-to-patient platforms — expanding access and transforming how patients connect to care.